IRadimed Corporation

IRMD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$19,234$17,193$12,828$9,325
Dep. & Amort.$818$765$671$1,407
Deferred Tax-$698-$1,172$57$524
Stock-Based Comp.$2,525$2,187$1,394$1,459
Change in WC$3,749-$5,910-$5,056-$1,576
Other Non-Cash-$3$402$149$119
Operating Cash Flow$25,624$13,465$10,043$11,258
Investing Activities
PP&E Inv.-$8,005-$7,441-$823-$482
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$500$1,390
Other Inv. Act.-$812-$567-$1,052-$259
Investing Cash Flow-$8,817-$8,007-$1,375$648
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$30$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$13,677-$13,223-$12,559$0
Other Fin. Act.-$688-$434-$147$24
Financing Cash Flow-$14,336-$13,657-$12,706$24
Forex Effect$0$0$0$0
Net Chg. in Cash$2,472-$8,199-$4,039$11,931
Supplemental Information
Beg. Cash$49,762$57,961$62,000$50,069
End Cash$52,234$49,762$57,961$62,000
Free Cash Flow$17,619$5,458$8,168$10,516